A trial to learn how safe AZD4063 is, how it moves throughout the body over time, and how it affects the levels of PLN mRNA in adults with dilated cardiomyopathy because of an R14del mutation in the PLN gene- D8340C00001
Latest Information Update: 25 Nov 2025
At a glance
- Drugs AZD 4063 (Primary)
- Indications Dilated cardiomyopathy
- Focus First in man; Pharmacokinetics
- Sponsors AstraZeneca
Most Recent Events
- 25 Nov 2025 New trial record